Compliance with an experimental drug regimen for treatment of asthma: Its magnitude, importance, and correlates

Karen Glanz, Stanley Fiel, Morris A. Swartz, Mildred E. Francis

Research output: Contribution to journalArticle

12 Citations (Scopus)

Abstract

This paper reports on data from a double-blind, randomized controlled study of out-patient use of corticosteroids following an acute asthma attack. Issues related to compliance are examined, including: (1) the extent of non-compliance; (2) impact of non-compliance on interpreting the drug trial results; and (3) correlates of non-compliance. Of the 102 cases enrolled in the study, 25.5% were excluded from analysis because they were lost to follow-up (10.8%) or non-compliers (14.7%). Based on data for compliers, the drugs were found to reduce relapse rates and asthma symptomatology; when non-compliers were included in the analysis, the steroid drug appeared ineffective for reducing relapses and less effective for improving overall illness status. Examination of 24 potential correlates of compliance yielded few significant associations, and only the "usual habit of compliance" correlation suggests an avenue for future action. The implications of the study findings for design and interpretation of clinical trials, as well as for improved management of chronic diseases, are discussed.

Original languageEnglish (US)
Pages (from-to)815-824
Number of pages10
JournalJournal of Chronic Diseases
Volume37
Issue number11
DOIs
StatePublished - Jan 1 1984
Externally publishedYes

Fingerprint

Compliance
Asthma
Pharmaceutical Preparations
Recurrence
Lost to Follow-Up
Habits
Adrenal Cortex Hormones
Chronic Disease
Outpatients
Steroids
Clinical Trials

All Science Journal Classification (ASJC) codes

  • Epidemiology

Cite this

@article{79727c85bf7a4ad9a10190e033f77b57,
title = "Compliance with an experimental drug regimen for treatment of asthma: Its magnitude, importance, and correlates",
abstract = "This paper reports on data from a double-blind, randomized controlled study of out-patient use of corticosteroids following an acute asthma attack. Issues related to compliance are examined, including: (1) the extent of non-compliance; (2) impact of non-compliance on interpreting the drug trial results; and (3) correlates of non-compliance. Of the 102 cases enrolled in the study, 25.5{\%} were excluded from analysis because they were lost to follow-up (10.8{\%}) or non-compliers (14.7{\%}). Based on data for compliers, the drugs were found to reduce relapse rates and asthma symptomatology; when non-compliers were included in the analysis, the steroid drug appeared ineffective for reducing relapses and less effective for improving overall illness status. Examination of 24 potential correlates of compliance yielded few significant associations, and only the {"}usual habit of compliance{"} correlation suggests an avenue for future action. The implications of the study findings for design and interpretation of clinical trials, as well as for improved management of chronic diseases, are discussed.",
author = "Karen Glanz and Stanley Fiel and Swartz, {Morris A.} and Francis, {Mildred E.}",
year = "1984",
month = "1",
day = "1",
doi = "10.1016/0021-9681(84)90014-6",
language = "English (US)",
volume = "37",
pages = "815--824",
journal = "Journal of Clinical Epidemiology",
issn = "0895-4356",
publisher = "Elsevier USA",
number = "11",

}

Compliance with an experimental drug regimen for treatment of asthma : Its magnitude, importance, and correlates. / Glanz, Karen; Fiel, Stanley; Swartz, Morris A.; Francis, Mildred E.

In: Journal of Chronic Diseases, Vol. 37, No. 11, 01.01.1984, p. 815-824.

Research output: Contribution to journalArticle

TY - JOUR

T1 - Compliance with an experimental drug regimen for treatment of asthma

T2 - Its magnitude, importance, and correlates

AU - Glanz, Karen

AU - Fiel, Stanley

AU - Swartz, Morris A.

AU - Francis, Mildred E.

PY - 1984/1/1

Y1 - 1984/1/1

N2 - This paper reports on data from a double-blind, randomized controlled study of out-patient use of corticosteroids following an acute asthma attack. Issues related to compliance are examined, including: (1) the extent of non-compliance; (2) impact of non-compliance on interpreting the drug trial results; and (3) correlates of non-compliance. Of the 102 cases enrolled in the study, 25.5% were excluded from analysis because they were lost to follow-up (10.8%) or non-compliers (14.7%). Based on data for compliers, the drugs were found to reduce relapse rates and asthma symptomatology; when non-compliers were included in the analysis, the steroid drug appeared ineffective for reducing relapses and less effective for improving overall illness status. Examination of 24 potential correlates of compliance yielded few significant associations, and only the "usual habit of compliance" correlation suggests an avenue for future action. The implications of the study findings for design and interpretation of clinical trials, as well as for improved management of chronic diseases, are discussed.

AB - This paper reports on data from a double-blind, randomized controlled study of out-patient use of corticosteroids following an acute asthma attack. Issues related to compliance are examined, including: (1) the extent of non-compliance; (2) impact of non-compliance on interpreting the drug trial results; and (3) correlates of non-compliance. Of the 102 cases enrolled in the study, 25.5% were excluded from analysis because they were lost to follow-up (10.8%) or non-compliers (14.7%). Based on data for compliers, the drugs were found to reduce relapse rates and asthma symptomatology; when non-compliers were included in the analysis, the steroid drug appeared ineffective for reducing relapses and less effective for improving overall illness status. Examination of 24 potential correlates of compliance yielded few significant associations, and only the "usual habit of compliance" correlation suggests an avenue for future action. The implications of the study findings for design and interpretation of clinical trials, as well as for improved management of chronic diseases, are discussed.

UR - http://www.scopus.com/inward/record.url?scp=0021737336&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=0021737336&partnerID=8YFLogxK

U2 - 10.1016/0021-9681(84)90014-6

DO - 10.1016/0021-9681(84)90014-6

M3 - Article

C2 - 6389582

AN - SCOPUS:0021737336

VL - 37

SP - 815

EP - 824

JO - Journal of Clinical Epidemiology

JF - Journal of Clinical Epidemiology

SN - 0895-4356

IS - 11

ER -